In Brief This Week: Sequenom; Promega; Danaher; Agilent; Horizon Discovery; Silicon Biosystems; Warnex | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sequenom this week said that the American Journal of Obstetrics and Gynecology has accepted for publication a manuscript that details the results of the firm's "locked-assay" study on its Trisomy 21 test. It did not provide a planned date for the article.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.